Canada / Federal Consultations on a National Strategy for Rare Disease Drugs
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health…
Novartis Pharmaceuticals Canada Inc.
Last updated: 01.06.2015
Novartis Pharmaceuticals Canada Inc.
385, blvd Bouchard
CDN- Dorval, Quebec H9S 1A9
CANADA
Phone +1 514 6316775 Fax +1 514 6311867 www.novartis.com
Novartis, a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians. Novartis delivers innovative medicines and vaccines to Canadians and healthcare professionals that make important contributions to improving and saving lives. It is headquartered in Dorval, Quebec.
In just over a decade, Novartis Pharmaceuticals Canada has introduced more than 25 new medicines. These treatments have had an important impact on patients suffering from a wide variety of major illnesses, such as: chronic obstructive pulmonary disease (COPD), cystic fibrosis, multiple sclerosis, cancer, age-related macular degeneration and metabolic disease, asthma and osteoporosis. Patients who have had an organ transplant have also benefited from the company’s innovative portfolio.
In 2012, the company invested close to $100 million in research and development in Canada. Novartis Pharmaceuticals Canada Inc. employs more than 600 people in Canada. For further information, please consult www.novartis.ca.
Related
Canada / The Evolution of Medical Cannabis Legislation
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical cannabis industry in Canada, its…
Canada / Has the Time Truly Come for Trudeau’s ‘National Pharmacare’?
As the only country in the world to boast a universal healthcare system that does not cover prescription drugs,…
Canada / Pharma News Roundup September 2020
The latest news from Canadian pharma including deals for J&J’s and Novavax’s COVID-19 vaccines, an abrupt…
Pricing / Drugmakers Push Back Against Canada's New Regulations
Pushback from drug companies on Canada’s newest drug pricing regulations has led the country’s regulatory…
Alzheimer's / Canadian-Led Innovation Post-Aducanumab
Dr Neil Cashman looks at the potential impact of US FDA approval for Biogen’s aducanumab on the search for…
Canada / Global Pharma has Reinvented R&D: Will Canadian Start-Ups Lead the Next Phase?
John L. Wallace of Antibe Therapeutics highlights how Canadian innovation stands to put the country at the…
Opinion / A New Approach to Rare Diseases in Canada
Pamela Fralick of Innovative Medicines Canada (IMC) advocates for a collaborative multi-stakeholder approach to…
Pharma Faces / Marina Vasiliou, Biogen Canada
Marina Vasiliou took the reins as managing director of Biogen Canada in November 2017 after a long and varied…
Canada / Collective Impact in the Health Charity Sector
Diabetes Canada’s Jan Hux outlines how her organization has been able to shift from small, local programs to…
Patents: A Key Factor in Winning the Cannabis Arms Race
A new white paper from Fasken law firm asserts that the early filing of patents for innovative products is crucial…
Comprehensive Access to Medicines should be the Priority for National Pharmacare…
Canada is the only developed country with a universal healthcare system that does not provide universal coverage of…
